tradingkey.logo

Neogenomics Inc

NEO
11.420USD
+0.150+1.33%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
1.47BMarktkapitalisierung
VerlustKGV TTM

Neogenomics Inc

11.420
+0.150+1.33%

mehr Informationen über Neogenomics Inc Unternehmen

NeoGenomics, Inc. is a cancer diagnostics company specializing in cancer genetics testing and information services. The Company offers comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with diagnostic and predictive testing to help them diagnose and treat cancer. Its services include clinical cancer testing; interpretation and consultative services; molecular and NGS testing; comprehensive technical and professional services offering; clinical trials and research; validation laboratory services, and oncology data solutions. It operates a network of laboratories for full-service sample processing and analysis services throughout the United States and a full-service sample-processing laboratory in Cambridge, United Kingdom. Its testing services include Cytogenetics (karyotype analysis), Fluorescence In-Situ Hybridization (FISH), Flow cytometry, and others.

Neogenomics Inc Informationen

BörsenkürzelNEO
Name des UnternehmensNeogenomics Inc
IPO-datumDec 10, 2012
CEOZook (Antony P)
Anzahl der mitarbeiter2200
WertpapierartOrdinary Share
GeschäftsjahresendeDec 10
Addresse9490 Neogenomics Way
StadtFORT MYERS
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl33912
Telefon12397680600
Websitehttps://neogenomics.com/
BörsenkürzelNEO
IPO-datumDec 10, 2012
CEOZook (Antony P)

Führungskräfte von Neogenomics Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Jeffrey Scott (Jeff) Sherman
Mr. Jeffrey Scott (Jeff) Sherman
Chief Financial Officer
Chief Financial Officer
174.72K
-11938.00%
Mr. Warren Stone
Mr. Warren Stone
President, Chief Operating Officer
President, Chief Operating Officer
121.63K
+22127.00%
Mr. Stephen Michael Kanovsky
Mr. Stephen Michael Kanovsky
Independent Director
Independent Director
52.34K
+12254.00%
Dr. Neil Gunn
Dr. Neil Gunn
Independent Director
Independent Director
28.10K
+12254.00%
Ms. Felicia Williams
Ms. Felicia Williams
Independent Director
Independent Director
7.16K
+7160.00%
Ms. Lynn A. Tetrault, J.D.
Ms. Lynn A. Tetrault, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Alison L. Hannah, M.D.
Dr. Alison L. Hannah, M.D.
Independent Director
Independent Director
--
--
Mr. Michael A. Kelly
Mr. Michael A. Kelly
Lead Independent Director
Lead Independent Director
--
--
Mr. David B. Perez
Mr. David B. Perez
Independent Director
Independent Director
--
--
Ms. Alicia Olivo
Ms. Alicia Olivo
Executive Vice President, General Counsel & Business Development
Executive Vice President, General Counsel & Business Development
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Jeffrey Scott (Jeff) Sherman
Mr. Jeffrey Scott (Jeff) Sherman
Chief Financial Officer
Chief Financial Officer
174.72K
-11938.00%
Mr. Warren Stone
Mr. Warren Stone
President, Chief Operating Officer
President, Chief Operating Officer
121.63K
+22127.00%
Mr. Stephen Michael Kanovsky
Mr. Stephen Michael Kanovsky
Independent Director
Independent Director
52.34K
+12254.00%
Dr. Neil Gunn
Dr. Neil Gunn
Independent Director
Independent Director
28.10K
+12254.00%
Ms. Felicia Williams
Ms. Felicia Williams
Independent Director
Independent Director
7.16K
+7160.00%
Ms. Lynn A. Tetrault, J.D.
Ms. Lynn A. Tetrault, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Clinical Services-Client direct billing
132.29M
70.44%
Clinical Services-Commercial Insurance
32.47M
17.29%
Clinical Services-Medicare and Medicaid
22.97M
12.23%
Clinical Services-Self-Pay
69.00K
0.04%
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Clinical Services-Client direct billing
132.29M
70.44%
Clinical Services-Commercial Insurance
32.47M
17.29%
Clinical Services-Medicare and Medicaid
22.97M
12.23%
Clinical Services-Self-Pay
69.00K
0.04%

Aktionärsstatistik

Aktualisiert: Wed, Feb 4
Aktualisiert: Wed, Feb 4
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
13.59%
The Vanguard Group, Inc.
10.66%
First Light Asset Management, LLC
7.67%
Greenhouse Funds LLLP
6.35%
Millennium Management LLC
5.01%
Andere
56.71%
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
13.59%
The Vanguard Group, Inc.
10.66%
First Light Asset Management, LLC
7.67%
Greenhouse Funds LLLP
6.35%
Millennium Management LLC
5.01%
Andere
56.71%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
48.68%
Investment Advisor/Hedge Fund
31.58%
Hedge Fund
23.57%
Research Firm
2.97%
Individual Investor
1.31%
Pension Fund
1.26%
Bank and Trust
0.54%
Sovereign Wealth Fund
0.09%
Family Office
0.04%

Institutionelle Beteiligung

Aktualisiert: Mon, Jan 5
Aktualisiert: Mon, Jan 5
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
572
134.68M
104.09%
-7.79M
2025Q3
568
127.88M
98.83%
-9.78M
2025Q2
571
126.82M
98.17%
-12.95M
2025Q1
596
131.44M
102.13%
-4.71M
2024Q4
585
127.59M
99.32%
-7.82M
2024Q3
589
129.38M
100.96%
-8.76M
2024Q2
597
131.21M
102.74%
-9.36M
2024Q1
633
132.83M
104.04%
-13.13M
2023Q4
672
130.90M
102.70%
-12.18M
2023Q3
691
124.98M
98.00%
-16.78M
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
BlackRock Institutional Trust Company, N.A.
17.58M
13.59%
-189.58K
-1.07%
Sep 30, 2025
The Vanguard Group, Inc.
13.87M
10.72%
-227.03K
-1.61%
Sep 30, 2025
First Light Asset Management, LLC
9.93M
7.67%
+3.08M
+45.00%
Sep 30, 2025
Greenhouse Funds LLLP
8.22M
6.35%
+789.51K
+10.62%
Sep 30, 2025
Millennium Management LLC
6.48M
5.01%
+46.65K
+0.72%
Dec 02, 2025
State Street Investment Management (US)
5.02M
3.88%
-88.88K
-1.74%
Sep 30, 2025
Deerfield Management Company, L.P.
4.45M
3.44%
+2.30M
+107.05%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
3.83M
2.96%
-465.84K
-10.85%
Sep 30, 2025
Schroder Investment Management North America Inc.
3.48M
2.69%
-240.87K
-6.47%
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
State Street SPDR S&P Health Care Services ETF
2.38%
Invesco S&P SmallCap Health Care ETF
0.77%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.5%
Inspire Small/Mid Cap ESG ETF
0.32%
iShares U.S. Healthcare Providers ETF
0.2%
Invesco S&P SmallCap 600 QVM Multi-factor ETF
0.14%
iShares S&P Small-Cap 600 Value ETF
0.12%
Nuveen ESG Small-Cap ETF
0.11%
iShares ESG Select Screened S&P Small-Cap ETF
0.1%
iShares Core S&P Small-Cap ETF
0.09%
Mehr Anzeigen
State Street SPDR S&P Health Care Services ETF
Anteil2.38%
Invesco S&P SmallCap Health Care ETF
Anteil0.77%
First Trust Nasdaq Lux Digi Health Solutions ETF
Anteil0.5%
Inspire Small/Mid Cap ESG ETF
Anteil0.32%
iShares U.S. Healthcare Providers ETF
Anteil0.2%
Invesco S&P SmallCap 600 QVM Multi-factor ETF
Anteil0.14%
iShares S&P Small-Cap 600 Value ETF
Anteil0.12%
Nuveen ESG Small-Cap ETF
Anteil0.11%
iShares ESG Select Screened S&P Small-Cap ETF
Anteil0.1%
iShares Core S&P Small-Cap ETF
Anteil0.09%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI